Related Experiment Video
Updated: Mar 23, 2026

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
Published on: July 31, 2016
Cognitive Testing of an Electronic Version of the Faces Pain Scale-Revised with Pediatric and Adolescent Sickle Cell
Neehar Gupta1, April N Naegeli2, Diane M Turner-Bowker3
1Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. ngupta@lilly.com.
Insights
The electronic Faces Pain Scale-Revised (FPS-R) is understandable for children aged 7 and older with sickle cell disease (SCD). This validated pain scale is useful for future clinical studies involving pediatric SCD patients.
Area of Science:
- Pediatric Hematology
- Pain Management
- Clinical Informatics
Background:
- Patient-reported outcomes are crucial for managing pediatric pain at home.
- The Faces Pain Scale-Revised (FPS-R) is a reliable pain assessment tool for children.
- Validation of the FPS-R in children with sickle cell disease (SCD) is lacking.
Purpose of the Study:
- To assess the comprehension and usability of an electronic, modified FPS-R in pediatric patients with SCD.
- To determine the age-appropriateness and ease of use of the electronic FPS-R for SCD patients.
Main Methods:
- A cross-sectional, qualitative study design was employed.
- In-person interviews and cognitive debriefing were conducted with children (4-17 years) with SCD and their parents in the USA.
- Usability testing of the electronic FPS-R was performed.
Main Results:
- Children aged 4-6 years demonstrated limited understanding of the FPS-R.
- Children aged 7-8 years understood the scale but often required parental assistance.
- Children aged 9-17 years could independently comprehend and use the electronic FPS-R.
- The majority of participants found the electronic device user-friendly.
Conclusions:
- The electronic FPS-R is a comprehensible and usable pain measurement tool for children aged 7-17 with SCD.
- The validated electronic FPS-R can be beneficial for future clinical research in pediatric SCD.
- This study supports the use of digital pain assessment tools in managing SCD pain.
Background:
Patient diaries and pain scales can capture the course and complications of pain managed at home in children. The Faces Pain Scale-Revised (FPS-R) is a validated scale showing reliability in children, but it has not been validated in children with sickle cell disease (SCD).
Objective:
The purpose of this study was to evaluate comprehension and usability of an electronic modified version of the FPS-R among pediatric patients with SCD.
Methods:
This was a cross-sectional, qualitative study involving in-person interviews with children/adolescents from the USA and their parents/legal guardians. Interviews involved cognitive debriefing and usability testing of the FPS-R.
Results:
In total, 22 children with SCD aged 4-17 years participated. Children aged 4-6 were generally unable to demonstrate clear understanding of the FPS-R and its response scale. Overall, children aged ≥7 years understood the instrument and could complete it on the electronic device, although children aged 7-8 often needed assistance from the parent. Children aged 9-17 years were able to read and complete the instrument independently. Most participants considered the electronic device easy to use.
Conclusions:
The FPS-R was shown to be a comprehensible and usable pain measure for children aged 7-17 with SCD and to be beneficial for future clinical studies.
More Related Videos
08:09Psychophysiological Assessment of the Effectiveness of Emotion Regulation Strategies in Childhood
Published on: February 11, 2017
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015